That’s the abbreviation for hypoactive sexual desire disorder. It’s a common, treatable medical condition characterized by ongoing low sexual desire that women find frustrating. (“hypoactive” means “low”) If you’re diagnosed with “acquired, generalized” HSDD, it means you haven’t had low sexual desire in the past, but you now have low sexual desire, no matter the […]
Vyleesi (bremelanotide injection) is the first and only FDA-approved as-needed treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). It was approved by the FDA on June 21, 2019. Do not use if you have: high blood pressure that is not controlled (uncontrolled hypertension) known heart (cardiovascular) disease See clinical trials info.
with an independent healthcare provider
Book NowDo not use VYLEESI if you have:
Before using VYLEESI, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. VYLEESI may affect the way other medicines work, and other medicines may affect the way VYLEESI works.
VYLEESI can cause serious side effects, including:
The most common side effects of VYLEESI include: flushing, injection site reactions, headache, vomiting, cough, fatigue, hot flush, tingling, dizziness, and nasal congestion. These are not all the possible side effects of VYLEESI.
Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit fda.gov/medwatch or call 1-800-FDA-1088.
VYLEESI is a prescription medicine used to treat hypoactive (low) sexual desire disorder (HSDD) in women who have not gone through menopause, who have not had problems with low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner. Women with HSDD have low sexual desire that is troubling to them. Their low sexual desire is not due to:
VYLEESI is not for the treatment of HSDD in women who have gone through menopause or in men.
VYLEESI is not for use to improve sexual performance.
VYLEESI is not for use in children.
You are now leaving Vyleesi.com to enter a website not owned or operated by Palatin Technologies, Inc. Prescribery is an innovative platform that helps pharmaceutical manufacturers connect independent providers directly with potential patients. You can speak to a provider in the privacy of your home, at a time that is convenient for you for no more than $49. Eligible patients pay a $0 copay for your first Vyleesi prescription. Then, pay no more than $99 for each eligible refill of four single-dose auto injectors.
Palatin is not affiliated with healthcare providers, does not make any recommendations of specific healthcare providers, and is not responsible for information you share with them. Any prescription is the decision of the healthcare provider alone, based on the patient's needs. Palatin does not accept any responsibility for the care, treatment, or advice received from any healthcare provider.
Are you a healthcare professional in the United States?
This website is intended for US healthcare professionals only.
*Each patient’s eligibility is evaluated on an individual basis. In compliance with federal regulations, patients insured by a government-funded program (Medicaid, TRICARE, etc.) are not eligible. Patients must be 18 or older to qualify. These programs and any assistance provided may be discontinued or modified at any time based on eligibility, state and local laws, and program availability.
Financial assistance applies to the patient’s copay, coinsurance, or deductible for patients receiving Vyleesi. Palatin contributions against patient deductible and/or out-of-pocket maximums are subject to possible health plan restrictions. Palatin Technologies, Inc. will help lower the out-of-pocket cost to a $0 copay for the patient’s first prescription. Palatin will also provide copay assistance to lower the out of pocket cost for refills to a maximum copay of $99 per 4-pack. Palatin copay assistance will only apply to 2 fills every 30 days. Enrollment into the program cannot be retroactive.
1.In the past, was your level of sexual desire or interest good and satisfying to you?
2.Has there been a decrease in your level of sexual desire or interest?
3.Are you bothered by your decreased level of sexual desire or interest?
4.Would you like your level of sexual desire or interest to increase?
5.Please circle any of the factors that you feel may be contributing to your current decrease in sexual desire or interest: